Immune classification of soft tissue sarcoma and its association with molecular characteristics, and clinical outcome

被引:2
|
作者
Petitprez, F. [1 ]
de Reynies, A. [2 ]
Chen, T. W-W. [3 ]
Sun, C-M. [1 ]
Lacroix, L. [1 ]
Adam, J. [4 ]
Toulmonde, M. [5 ]
Italiano, A. [6 ]
Sautes-Fridman, C. [1 ]
Fridman, W-H. [7 ]
机构
[1] Ctr Rech Cordeliers, Equipe Canc & Immun Antitumorale, Paris, France
[2] Ligue Natl Canc, Programme Cartes Ident Tumeurs, Paris, France
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Inst Gustave Roussy, Villejuif, France
[5] Inst Bergonie, Bordeaux, France
[6] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
[7] Ctr Rech Cordeliers, Canc, Immunol, Immunopathol, Paris, France
关键词
D O I
10.1093/annonc/mdy319.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
112O
引用
收藏
页码:35 / 35
页数:1
相关论文
共 50 条
  • [1] A novel transcriptomic-based immune classification of soft tissue sarcoma (STS) and its association with molecular characteristics, clinical outcome and response to therapy
    Petitprez, Florent
    Chen, Tom Wei-Wu
    Sun, Cheng-Ming
    Calderaro, Julien
    Hsiao, Li-Ping
    Lacroix, Laetitia
    Natario, Ivo
    Toulmonde, Maud
    Lucchesi, Carlo
    Laizet, Yec'han
    Italiano, Antoine
    de Reynies, Aurelien
    Sautes-Fridman, Catherine
    Fridman, Wolf H.
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Immune classification of soft tissue sarcoma predicts clinical outcome
    Petitprez, F.
    de Reynies, A.
    Keung, E. Z.
    Chen, T. W-W.
    Sun, C-M.
    Jeng, Y-M.
    Hsiao, L-P.
    Lacroix, L.
    Lucchesi, C.
    Toulmonde, M.
    Burgess, M. A.
    Bolejack, V.
    Reinke, D.
    Lazar, A. J.
    Roland, C. L.
    Wargo, J.
    Italiano, A.
    Sautes-Fridman, C.
    Tawbi, H. A.
    Fridman, W. H.
    ANNALS OF ONCOLOGY, 2019, 30 : 689 - 689
  • [3] Molecular classification of soft tissue sarcomas and its clinical applications
    Jain, Shilpa
    Xu, Ruliang
    Prieto, Victor G.
    Lee, Peng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2010, 3 (04): : 416 - 428
  • [4] Association of tumor growth on nude mice and poor clinical outcome in soft tissue sarcoma patients
    Budach, W
    Budach, V
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (09) : 523 - 530
  • [5] Association of tumor growth on nude mice and poor clinical outcome in soft tissue sarcoma patients
    Wilfried Budach
    Volker Budach
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 523 - 530
  • [6] Clinical significance of tumor immune microenvironment in soft tissue sarcoma
    Oike, Naoki
    Kawashima, Hiroyuki
    Ogose, Akira
    Hatano, Hiroshi
    Ariizumi, Takashi
    Sasaki, Taro
    Yamagishi, Tetsuro
    Umezu, Hajime
    Endo, Naoto
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Soft tissue sarcoma of the hand in children: Clinical outcome and management
    Gross, E
    Rao, BN
    Pappo, AS
    Michalkiewicz, E
    Hudson, MM
    Kaste, SC
    Greenwald, CA
    Pratt, CB
    JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (05) : 698 - 702
  • [8] A molecular signature predictive of clinical outcome following pazopanib therapy in advanced soft tissue sarcoma
    Huang, P.
    Lee, A.
    McCarthy, F.
    Thway, K.
    Morden, J.
    Messiou, C.
    Daley, F.
    Buus, R.
    Fisher, C.
    Cheang, M.
    Judson, I.
    Jones, R.
    ANNALS OF ONCOLOGY, 2017, 28 : 149 - 149
  • [9] Immune-based classification of soft-tissue sarcoma is associated with clinical outcome and unveils tertiary lymphoid structures as surrogate biomarker for the clinic
    Chen, Wei-Wu Tom
    Petitprez, Florent
    Sun, Cheng-Ming
    Lacroix, Laetitia
    De Reynies, Aurelien
    Italiano, Antoine
    Toulmonde, Maud
    Lucchesi, Carlo
    Laizet, Yec'han
    Sautes-Fridman, Catherine
    Fridman, Wolf Herve
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [10] Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma
    Tu, Chao
    Liu, Binfeng
    Li, Chenbei
    Feng, Chengyao
    Wang, Hua
    Zhang, Haixia
    He, Shasha
    Li, Zhihong
    MEDCOMM, 2023, 4 (05):